Study Pharmacoepidemiology This Fall

 

5573.  Pharmacoepidemiology  or  Learning How to Interpret Data in an Objective and Scientific Manner

Every product has its benefits and associated risks.  But what is the critical point when risks outweigh benefits, and what statistical methods does industry use to reach those decisions? 

At its core, pharmacoepidemiology is a quantitative discipline based on large patient populations.  Gaining a basic understanding of statistical principles and how they are applied by industry is an important skill set for Regulatory and QA professionals. 

While this is not a course in statistics, it provides even non-mathematically-inclined students with a comfort level in key areas of pharmacoepidemiology and statistical interpretation.  Basic statistical principles will be discussed and applied to various studies, showing how study design can impact outcomes. 

Students will gain first-hand experience in interpreting epidemiologic, clinical, and post-marketing studies, and learn why factors such as ratios and rates, exposure estimation, cost-benefit assessments, and risk-benefit analyses are so critical to the industry.  

Pharmacoepidemiology is required for the Certificate in Global Pharmacovigilance:  Benefit-Risk Analysis. 

Pharmacoepidemiology is also highly recommended for students focusing on Clinical Trials.

 

Two Learning Formats Available

Traditional Classroom Setting at Ft Washington
5573.  Pharmacoepidemiology (101)  crn: 23420
6:00 pm - 9:00 pm Thursdays:  Sept 12, 19, 26, Oct 3, 10, 17, 24, 31, Nov 7, 14, 21, Dec 5.  Meets 12 times plus final exam on Dec 5.  No class Nov 28. Make-ups, if needed, Dec 12 or 19. In-class, proctored exam:  Dec 5.
Faculty:  N. Cossrow

Online
5573.  Pharmacoepidemiology (990)  crn:  23784
5:30 pm - 8:30 pm Tuesdays:  Sept 17, 24, Oct 1, 8, 15, 22, 29, Nov 5, 12, 19, 26, Dec 3.  Meets 12 times plus final exam. Make-up, if needed, Dec 10.  In-class, proctored exam:  Oct 15 (tentative).
Faculty:  J. Cies

Registration is Now Open for Both Sections.